IMMUNE PHARMACEUTICALS INC Common Stock
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch IMNPQ and buy or sell other stocks, ETFs, and their options commission-free!About IMNPQ
Immune Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases. Its lead product, Bertilimumab, is a human monoclonal antibody that binds eotaxin-1, a chemokine that attracts eosinophils to the site of inflammation.
CEOAdeel Ahmed-Daudpota
CEOAdeel Ahmed-Daudpota
Employees—
Employees—
HeadquartersEnglewood Cliffs, New Jersey
HeadquartersEnglewood Cliffs, New Jersey
Founded1993
Founded1993
Employees—
Employees—
IMNPQ Key Statistics
Market cap181.90K
Market cap181.90K
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume3.03K
Average volume3.03K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.007
52 Week high$0.007
52 Week low$0.0001
52 Week low$0.0001
Stock Snapshot
IMMUNE PHARMACEUTICALS INC Common Stock(IMNPQ) stock is priced at $0.00, giving the company a market capitalization of 181.9K.
IMMUNE PHARMACEUTICALS INC Common Stock(IMNPQ) stock opened on 2025-12-04 at —. The price climbed to — and dipped to —.
IMMUNE PHARMACEUTICALS INC Common Stock(IMNPQ) shares are trading with a volume of 0, against a daily average of 3.03K.
During the past year, IMMUNE PHARMACEUTICALS INC Common Stock(IMNPQ) stock moved between $0.00 at its lowest and $0.01 at its peak.
During the past year, IMMUNE PHARMACEUTICALS INC Common Stock(IMNPQ) stock moved between $0.00 at its lowest and $0.01 at its peak.